Medications starting with
Poland-
The medicine is used in acute and chronic respiratory diseases when there is a problem with expectorating thick secretions. It helps to liquefy the secretion, facilitating expectoration and the clearing of the bronchi.
Dosage form: capsules, soft gelatin
Active substance Dosage bromhexine hydrochloride 8 mg ATC code: R06CB02
Manufacturer: Pharmaceutical Works POLPHARMA S.A. Medana Branch in Sieradz
-
The medicine is used for the symptomatic treatment of respiratory diseases, such as inflammation of the sinuses, bronchi, lungs, larynx, nose, and throat, when there is excessive production of thick and sticky secretion.
Dosage form: solution for oral use, granules
Active substance Dosage carbocysteine lysine salt 2700 mg ATC code: R05CB03
Manufacturer: Laboratorios Alcala Farma, S.L.
-
The medicine is used in acute and chronic respiratory diseases characterized by difficulties in expectoration and mucus removal. It acts mucolytically, facilitating the removal of secretions from the lungs.
Dosage form: syrup
Active substance Dosage bromhexine hydrochloride 1.6 mg ATC code: R05CB02
Manufacturer: Laboratórios Basi - Pharmaceutical Industry, S.A.
-
The medicine is used in acute and chronic respiratory diseases characterized by difficulties in expectorating and removing mucus. It acts mucolytically, thinning the secretion, which facilitates expectoration and relieves coughing.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage bromhexine hydrochloride 4 mg ATC code: R05CB02
Manufacturer: Mako Pharma Sp. z o.o.
-
It is used in acute and chronic respiratory diseases associated with problems with expectoration and mucus removal. It acts mucolytically, facilitating expectoration and relieving cough.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage bromhexine hydrochloride 8 mg ATC code: R05CB02
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is used to replenish and maintain circulating blood volume in situations where it is too low.
Dosage form: solution for infusion
Active substance Dosage human albumin 200 g/l ATC code: B05AA01
Manufacturer: Takeda Manufacturing Austria AG
-
The medicine is used to relieve the symptoms of mild to moderate knee osteoarthritis.
Dosage form: tablets
Active substance Dosage glucosamine 625 mg ATC code: M01AX05
Manufacturer: Laboratoires Expanscience
-
The medicine is used to prevent breathing problems occurring in asthma. It helps to prevent shortness of breath and wheezing.
Dosage form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 50 mcg ATC code: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing.
Dosage form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 125 mcg ATC code: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA SA
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to prevent shortness of breath and wheezing in the airways.
Dosage form: aerosol, inhalation suspension
Active substance Dosage salmeterol xinafoate 36.32 mcg fluticasone propionate 250 mcg ATC code: R03AK06
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA SA
-
The medicine is used for the prevention and treatment of seasonal and perennial allergic rhinitis (including hay fever), as well as for the symptomatic treatment of nasal polyps. It helps to reduce swelling, irritation, itching, sneezing, and runny nose.
Dosage form: spray, nasal suspension
Active substance Dosage fluticasone propionate 0.05 g ATC code: R01AD08
Manufacturer: Glaxo Wellcome S.A.
-
The medicine is used to treat nasal polyps and related symptoms, such as reduction of swelling, irritation, itching, sneezing, nasal congestion, or runny nose.
Dosage form: drops nasal suspension
Active substance Dosage fluticasone propionate 400 mcg ATC code: R01AD08
Manufacturer: GlaxoSmithKline Trading Services Limited
-
The medicine is used for the prevention of bronchial asthma in adults (mild, moderate, or severe) and in children who require preventive medication.
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 50 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production Glaxo Wellcome S.A.
-
The medicine is used for the prevention of bronchial asthma in adults (mild, moderate, or severe) and in children who require preventive medication.
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production Glaxo Wellcome S.A.
-
The medicine is used to prevent asthma attacks in adults and children over 16 years of age, as well as in the treatment of chronic obstructive pulmonary disease (COPD).
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 250 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production Glaxo Wellcome S.A.
-
The medicinal product is used for the prevention of severe bronchial asthma in adults and adolescents over 16 years of age. In children aged 4 to 16 years, it is used to treat exacerbations of bronchial asthma.
Dosage form: suspension for nebulization
Active substance Dosage fluticasone propionate 2 mg ATC code: R03BA05
Manufacturer: GlaxoSmithKline Trading Services Limited
-
The medicine is used for the prevention of severe bronchial asthma in adults and adolescents over 16 years of age. In children aged 4 to 16 years, it is used to treat exacerbations of bronchial asthma.
Dosage form: suspension for nebulization
Active substance Dosage fluticasone propionate 0.5 mg ATC code: R03BA05
Manufacturer: GlaxoSmithKline Trading Services Limited
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 250 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 50 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also indicated for the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 100 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 500 mcg ATC code: R03BA05
Manufacturer: Glaxo Wellcome Production
-
These drops are used to treat bacterial eye infections, such as conjunctivitis.
Dosage form: drops, ophthalmic solution
Active substance Dosage moxifloxacin 5 mg/ml ATC code: S01AE07
Manufacturer: Farmak International Sp. z o.o.
-
The medicine relieves allergic symptoms, such as sneezing, watery nasal discharge, itching of the nose or palate, and redness and watering of the eyes. It also helps with chronic urticaria, relieving skin wheals, swelling, and itching.
Dosage form: tablets
Active substance Dosage loratadine 10 mg ATC code: R06AX13
Manufacturer: Lek Pharmaceuticals d.d.
-
The medicine relieves allergic symptoms, such as sneezing, watery nasal discharge, itching of the nose or palate, redness and watering of the eyes, as well as wheals on the skin, swelling, and itching in chronic urticaria.
Dosage form: suspension, oral
Active substance Dosage loratadine 1 mg ATC code: R06AX13
Manufacturer: Lek Pharmaceuticals d.d.
-
It is used to treat infections of the anterior segment of the eye caused by bacteria sensitive to it, such as chronic conjunctivitis, keratitis, corneal ulcers, or chlamydia infections.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Dr. Gerhard Mann Chem-pharm. Fabrik GmbH
-
The medicine is used for infections of the anterior segment of the eye caused by bacteria, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, hordeolum (stye), or corneal ulcer.
Dosage form: drops, ophthalmic solution
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Dr. Gerhard Mann Chem. - Pharm. Fabrik GmbH
-
It is used for infections of the anterior segment of the eye caused by bacteria sensitive to it, for example, in cases of chronic conjunctivitis, keratitis, corneal ulcer, or chlamydial infection.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Bausch + Lomb Ireland limited
-
It is used for infections of the anterior segment of the eye caused by appropriate bacteria, such as chronic conjunctivitis, keratitis, corneal ulcers, or chlamydia infections.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Bausch+Lomb Ireland Ltd.
-
It is used for infections of the anterior segment of the eye caused by bacteria sensitive to it, for example, in chronic conjunctivitis, keratitis, corneal ulcers, or chlamydial infections.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Dr. Gerhard Mann Chem. - Pharm. Fabrik GmbH
-
The medicine is used for infections of the anterior segment of the eye, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, a stye, or corneal ulcer.
Dosage form: drops, ophthalmic solution
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Bausch+Lomb Ireland Ltd.
-
The medicine is used for infections of the anterior segment of the eye, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, stye, and corneal ulcer.
Dosage form: drops, ophthalmic solution
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Bausch + Lomb Ireland limited
-
It is used to treat bacterial infections of the anterior segment of the eye, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, a stye, or a corneal ulcer.
Dosage form: drops, ophthalmic solution
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Bausch + Lomb Ireland limited
-
The medicine is used for infections of the anterior segment of the eye caused by microorganisms sensitive to it. It helps, among other things, in chronic conjunctivitis, keratitis, corneal ulcers, and chlamydia infections.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Dr Gerhard Mann Chem.-Pharm. Factory GmbH
-
It is used in infections of the anterior segment of the eye caused by bacteria sensitive to it, for example in chronic conjunctivitis, keratitis, corneal ulcer, or chlamydial infection.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Bausch+Lomb Ireland Ltd.
-
The medicine is used for bacterial infections of the anterior segment of the eye, such as chronic conjunctivitis, keratitis, corneal ulcers, or chlamydia infections.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH
-
The medicine is used for infections of the anterior segment of the eye caused by bacteria sensitive to it, such as chronic conjunctivitis, keratitis, corneal ulcer, or chlamydia infection.
Dosage form: ointment, for eyes
Active substance Dosage ofloxacin 3 mg/g ATC code: S01AE01
Manufacturer: Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH
-
The medicine is used in the case of infections of the anterior segment of the eye caused by bacteria, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, a stye, or corneal ulcer.
Dosage form: drops, ophthalmic solution
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH
-
The medicine is used for infections of the anterior segment of the eye, such as bacterial conjunctivitis, keratitis, blepharitis, dacryocystitis, stye, and corneal ulcer.
Dosage form: drops, ophthalmic solution
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Bausch+Lomb Ireland Ltd.
-
The medicine is used to treat bacterial eye infections, such as conjunctivitis.
Dosage form: drops, ophthalmic solution
Active substance Dosage moxifloxacin 5 mg/ml ATC code: S01AE07
Manufacturer: Warsaw Pharmaceutical Works POLFA
-
The medicinal product is used exclusively for diagnostic purposes during PET scans. It helps to determine the location of malignant tumors by labeling cells undergoing very intense division processes.
Dosage form: solution for injection
Active substance Dosage fluorothymidine f 18 1000 MBq/ml ATC code: V09
Manufacturer: Synektik Pharma Sp. z o.o.
-
It is used in psychotic disorders without depressive disorders and as an emergency treatment in depressive disorders (other than those occurring during psychosis). It helps to alleviate symptoms of low mood.
Dosage form: tablets, film-coated
Active substance Dosage flupentixol dihydrochloride 0.584 mg ATC code: N05AF01
Manufacturer: H. Lundbeck A/S
-
It is used in the treatment of schizophrenia.
Dosage form: tablets, film-coated
Active substance Dosage flupentixol dihydrochloride 3.504 mg ATC code: N05AF01
Manufacturer: H. Lundbeck A/S
-
The medicine is used in the treatment of schizophrenia and other related psychoses.
Dosage form: solution for injection
Active substance Dosage flupentixol decanoate 20 mg/ml ATC code: N05AF01
Manufacturer: H. Lundbeck A/S
-
The vaccine is used to prevent influenza in adults and children from 6 months of age.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage a/victoria/4897/2022 (h1n1)pdm09 influenza virus strain 15 mcg influenza a virus strain a/croatia/10136rv/2023 (h3n2) 15 mcg influenza virus b/austria/1359417/2021 strain 15 mcg ATC code: J07BB02
Manufacturer: GlaxoSmithKline Biologicals Filia SmithKline Beecham Pharma GmbH & Co. KG
-
It helps protect against influenza, especially in individuals at risk of complications. It protects against four strains of the influenza virus.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage influenza a/victoria/4897/2022 (h1n1)pdm09 vaccine No input provided influenza vaccine a/croatia/10136rv/2023 (h3n2) No input provided influenza vaccine b/austria/1359417/2021 No input provided influenza vaccine b/phuket/3073/2013 No input provided ATC code: J07BB02
Manufacturer: GlaxoSmithKline Biologicals Filia SmithKline Beecham Pharma GmbH & Co. KG
-
The medicine is used topically for the treatment of acute and severe, non-infectious, dry skin inflammations, such as: seborrheic or atopic dermatitis, lichen nitidus, allergic contact eczema, erythema multiforme, lupus erythematosus, psoriasis (scalp or plaque), and lichen planus.
Dosage form: gel
Active substance Dosage fluocinolone acetonide 0.25 mg ATC code: D07AC04
Manufacturer: Jelfa Pharmaceutical Enterprise S.A.
-
The ointment is intended for the short-term treatment of acute and severe, dry skin inflammations that respond to glucocorticoids. It is used, among others, in seborrheic and atopic dermatitis, urticarial lichenoid dermatitis, contact eczema, erythema multiforme, lupus erythematosus, psoriasis, and lichen planus.
Dosage form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC code: D07AC04
Manufacturer: Bausch Health Ireland Limited
-
It is used for short-term, topical treatment of acute and severe, dry skin inflammations that cause persistent itching or excessive keratinization. It helps, among others, in seborrheic and atopic dermatitis, psoriasis, lichen planus, or contact dermatitis.
Dosage form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC code: D07AC04
Manufacturer: PharmaSwiss Czech Republic s.r.o.
-
The ointment is intended for short-term, topical treatment of acute and severe, dry skin inflammations that cause persistent itching or excessive keratinization. It is used, among others, in seborrheic dermatitis, atopic dermatitis, urticarial lichen planus, contact eczema, erythema multiforme, lupus erythematosus, psoriasis, and lichen planus.
Dosage form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC code: D07AC04
Manufacturer: Bausch Health Ireland Limited
-
The ointment is intended for short-term, topical treatment of acute and severe, non-infectious, dry skin inflammation that causes persistent itching or excessive keratinization. It is used, among others, in seborrheic dermatitis, atopic dermatitis, urticarial lichenoid dermatitis, contact eczema, psoriasis, or lichen planus.
Dosage form: ointment
Active substance Dosage fluocinolone acetonide 0.25 mg/g ATC code: D07AC04
Manufacturer: Bausch Health Ireland Ltd.